Physician profile
Omar Hussian
NPI 1437519824
$5,457.62
in general payments reported to CMS, 2019-2025
14 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $1,429 · 2021: $2,072 · 2022: $1,148 · 2023: $512 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,778.57 | 2020-2023 | |
| Medtronic, INC. | $1,191.71 | 2021-2023 | Corevalve Evolut R |
| W. L. Gore & Associates, INC. | $363.15 | 2021-2022 | |
| Edwards Lifesciences Corporation | $209.38 | 2022-2025 | |
| Abbott Laboratories | $201.89 | 2022-2023 | Epic |
| Baxter Healthcare | $159.52 | 2020-2023 | Coseal |
| Medtronic Vascular, INC. | $147.25 | 2020 | |
| Cook Medical LLC | $120.93 | 2023 | Cook |
| Medtronic USA, INC. | $89.18 | 2019 | |
| Abiomed | $61.21 | 2022-2023 | Impella |
| Tepha INC | $60.42 | 2019-2020 | |
| Gilead Sciences, INC. | $38.40 | 2023 | |
| Stryker Corporation | $19.55 | 2020 | |
| Livanova USA, INC. | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hussian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.